Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lixisenatide vs Sulfonylurea in T2DM during Ramadan
NCT02941367Phase 4Completed
- Sponsor
- Sanofi
- Start
- Feb 2017
- Primary completion
- Aug 2017
- Modality
- Peptides
- Countries
- 4
01
Overview
A Phase 4 trial of lixisenatide in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Feb 2017; status: completed.
02
Drugs
lixisenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02941367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02941367.